$NWBO Cashflow Statement | Understand Stock

$NWBO

$0.17 -$0.00 (0.15%) Close

$NWBO Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated statements of cash flows

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Cash Flows from Operating Activities:
Net loss
Reconciliation of net loss to net cash used in operating activities:
Depreciation and amortization
Amortization of debt discount
Change in fair value of derivatives
Change in fair value of share payable
Change in fair value of convertible notes
Loss from extinguishment of debt
Convertible notes payable
Total loss from extinguishment of debt
Inducement expense
Loss from issuance of debt
Amortization of operating lease right-of-use asset
Stock-based compensation for services
Warrant modifications associated with convertible notes under fair value option
Non-cash financing cost
Subtotal of non-cash charges
Changes in operating assets and liabilities:
Prepaid expenses and other current assets
Other non-current assets
Accounts payable and accrued expenses
Related party accounts payable and accrued expenses
Lease liabilities
Net cash used in operating activities

Cash Flows from Investing Activities:
Purchase of equipment and construction in progress
Loan receivable
Net cash used in investing activities
Cash Flows from Financing Activities:
Proceeds from issuance of Series C convertible preferred stock
Proceeds from issuance of Series C convertible preferred stock by common stock warrant exercise, net of debt redemption
Proceeds from issuance of common stock
Proceeds from issuance of common shares
Proceeds from investor advance
Proceeds from issuance of notes payable, net
Proceeds from issuance of convertible notes payable, net
Proceeds from contingent payment obligation
Repayment of notes payable
Repayment of convertible notes payable
Repayment of investor advances
Net cash provided by financing activities

Effect of exchange rate changes on cash and cash equivalents
Net increase in cash and cash equivalents
Cash and cash equivalents, beginning of the year
Cash and cash equivalents, end of the year
Supplemental disclosure of cash flow information
Interest payments
Notes payable
Notes
Convertible notes payable

Supplemental schedule of non-cash activities:
Cashless warrants and stock options exercise
Reclassification of warrant liabilities related to warrants exercised for cash
Reclassification of warrant liabilities to stockholders' deficit
Reclassification of warrant liabilities related to cashless warrants exercise
Reclassification of warrant liabilities based on authorized shares
Issuance of common stock for conversion of debt and accrued interest
Issuance of Series C preferred stock for conversion of debt and accrued interest
Convertible notes payable
Total issuance of Series C preferred stock for conversion of debt and accrued interest
Series C convertible preferred stock conversions
Capital expenditures included in accounts payable
Capital expenditures included in accounts payable and accrued expenses to related parties and affiliates
Issuance of common shares to settle accrued service liability
Reclassification between shares payable and equity
Issuance of Series C convertible preferred stock in lieu of debt redemption
Exercise common stock warrants by debt redemption
Deemed dividend related to warrant modifications
Debt discount related to warrant modifications
Offering cost related to warrant modification associated with a security purchase agreement
Reclassification between contingent payment obligation and convertible notes payable at fair value
Reclassification of investor advances to convertible notes payable
Reclassification of investor advances to stockholders' deficit
Reclass earned but unissued milestone shares from equity to liability
Reclassification of liability classified warrants to equity
Reclassification of equity classified warrants to warrant liabilities
Right-of-use asset recognized in exchange for lease liability
Equity contribution from acquisition of Advent
Contract balances due to Seller - related party
Common shares returned from acquisition

Comments